BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 103 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $4,155,000 | +1.2% | 510,408 | +0.4% | 0.00% | 0.0% |
| Q4 2018 | $4,104,000 | -46.8% | 508,508 | -49.7% | 0.00% | 0.0% |
| Q3 2018 | $7,708,000 | +149.9% | 1,010,212 | +87.7% | 0.00% | +50.0% |
| Q2 2018 | $3,084,000 | +17.9% | 538,295 | -1.8% | 0.00% | 0.0% |
| Q1 2018 | $2,615,000 | -3.1% | 548,146 | -0.2% | 0.00% | 0.0% |
| Q4 2017 | $2,698,000 | +2.6% | 549,401 | +9.5% | 0.00% | 0.0% |
| Q3 2017 | $2,630,000 | +0.9% | 501,930 | +7.0% | 0.00% | 0.0% |
| Q2 2017 | $2,607,000 | -11.9% | 468,882 | +33.2% | 0.00% | 0.0% |
| Q1 2017 | $2,958,000 | +29.8% | 352,100 | -2.2% | 0.00% | 0.0% |
| Q4 2016 | $2,279,000 | +34.1% | 360,022 | -6.6% | 0.00% | +100.0% |
| Q3 2016 | $1,699,000 | +54.2% | 385,339 | -0.7% | 0.00% | 0.0% |
| Q2 2016 | $1,102,000 | +19.1% | 388,150 | +18.7% | 0.00% | 0.0% |
| Q1 2016 | $925,000 | -72.6% | 326,873 | 0.0% | 0.00% | -66.7% |
| Q4 2015 | $3,373,000 | -12.4% | 326,873 | -3.2% | 0.00% | 0.0% |
| Q3 2015 | $3,850,000 | -26.5% | 337,717 | -3.7% | 0.00% | -25.0% |
| Q2 2015 | $5,236,000 | +64.2% | 350,731 | -0.7% | 0.00% | +100.0% |
| Q1 2015 | $3,188,000 | -25.6% | 353,038 | +0.1% | 0.00% | -33.3% |
| Q4 2014 | $4,287,000 | +19.1% | 352,554 | -4.2% | 0.00% | 0.0% |
| Q3 2014 | $3,601,000 | -19.6% | 368,154 | +4.8% | 0.00% | 0.0% |
| Q2 2014 | $4,478,000 | +55875.0% | 351,228 | +7088.5% | 0.00% | – |
| Q2 2013 | $8,000 | – | 4,886 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $40,692,000 | 16.07% |
| Fairmount Funds Management LLC | 3,343,107 | $35,370,000 | 8.10% |
| Kynam Capital Management, LP | 936,563 | $9,909,000 | 2.53% |
| Velan Capital Investment Management LP | 225,000 | $2,381,000 | 2.42% |
| ORACLE INVESTMENT MANAGEMENT INC | 603,994 | $6,390,000 | 1.94% |
| TANG CAPITAL MANAGEMENT LLC | 1,200,000 | $12,696,000 | 1.93% |
| MPM BioImpact LLC | 639,089 | $6,762,000 | 1.88% |
| Ghost Tree Capital, LLC | 325,000 | $3,439,000 | 1.79% |
| Sarissa Capital Management LP | 1,390,790 | $14,715,000 | 1.48% |
| Prosight Management, LP | 176,680 | $1,869,000 | 1.47% |